SB1085 would require the Secretary of Health and Human Services to establish the MedShield program, an AI-enabled pandemic preparedness and response initiative that aggregates innovations from the public-private ecosystem and international partners to safeguard public health. The bill directs integration of recommendations from the National Security Commission on Artificial Intelligence and assigns HHS as the lead agency and coordinator under the Federal Emergency Management Agency framework for emergency public health and medical services.
It also signals a shift away from ad hoc responses by enabling a sustained, system-wide capability that continuously monitors threats and accelerates countermeasure development. A 180-day reporting requirement and multi-year appropriations are included to support implementation and scale.
At a Glance
What It Does
It creates the MedShield program within HHS to utilize AI and related technologies for real-time pathogen surveillance, faster vaccine development, therapeutics, and optimized distribution strategies. The program is designed to function as a national medical shield through a system-of-systems approach that coordinates public and private sector assets and international partners.
Who It Affects
Federal agencies coordinating pandemic response, especially HHS and FEMA under NRF, along with partner ministries and international allies. It also affects biotech and pharmaceutical companies, diagnostics developers, AI and data analytics firms, healthcare providers, and state and local public health departments engaged in response operations.
Why It Matters
The bill aims to institutionalize AI-enabled pandemic preparedness to reduce reliance on ad hoc interventions. It contemplates a continuous, coordinated, and interoperable framework across government and industry to improve detection, countermeasures, and distribution when a threat emerges.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The MedShield program is established within the Department of Health and Human Services to operate as a national AI-enabled pandemic defense. It will gather innovations from the public-private ecosystem and international partners to improve the speed and effectiveness of medical countermeasures.
The program is designed to monitor threats continuously and to coordinate efforts across agencies to safeguard public health.
To ensure coherence and execution, the bill directs the Secretary to develop a plan that integrates the National Security Commission on Artificial Intelligence recommendations with the responsibilities of HHS as the primary agency for emergency public health and medical services under the NRF. The plan requires collaboration with other federal agencies and select partners to achieve coordinated international action in response to a pandemic, ensuring that AI-driven capabilities are aligned across borders and sectors.The Act enumerates concrete AI capabilities it intends to leverage: real-time pathogen surveillance, accelerated vaccine development, therapeutics development, AI-enabled modeling to optimize tracking and distribution, and rapid manufacturing enhancements.
The overarching goal is to create a shield against both manmade and naturally occurring biological threats and to ensure the United States can respond quickly and effectively when a health emergency arises. A reporting requirement within 180 days will summarize the implementation plan, with an unclassified version for public release and a classified annex if needed.
Finally, the bill specifies defined terms and outlines a multi-year funding path to support ongoing activities.
The Five Things You Need to Know
The bill creates the MedShield program within HHS to use AI for pandemic preparedness and response.
It requires integrating NSCAI recommendations and coordinating interagency and international efforts under NRF guidance.
Core AI capabilities include real-time pathogen surveillance, accelerated vaccine development, therapeutics, and optimized distribution and manufacturing.
A 180-day unclassified report (with possible classified annex) detailing the implementation plan is required to Congress.
Funding ranges from $300 million in FY2025 to $500 million in FY2029, with unobligated funds remaining available until expended.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Findings and sense of Congress
The bill catalogs why a dedicated AI-enabled pandemic defense is needed, citing lessons from COVID-19 and the NSCAI conclusions that AI should be used to build an integrated bio defense program. It also expresses the sense of Congress that the next pandemic should not require a Warp Speed-like initiative and that a proactive program, coordinated across agencies and private partners, should be established to operationalize AI and system-of-systems integration to manage biological threats.
Establishment of the MedShield program
This section requires the Secretary of Health and Human Services to implement a pandemic preparedness and response program using AI and other relevant technologies, to be known as MedShield. The program is designed to gather innovations from domestic and international partners to improve the efficiency and effectiveness of medical responses and to act as a sustained shield against biological threats.
Plan and integration
The Secretary must develop an integration plan that aligns NSCAI recommendations with HHS responsibilities as the primary agency for the emergency support function on public health and medical services under NRF. It also requires consultation with heads of relevant federal agencies and select allies to ensure cross-agency and international interoperability and coordination in response to a pandemic.
Utilization of AI capabilities
The program will leverage AI to enable five key capabilities: real-time pathogen surveillance and tracking, accelerated vaccine identification and development, creation of therapeutics, AI-driven modeling for response optimization, and streamlined rapid manufacturing of vaccines and therapeutics. These capabilities are intended to work together as an integrated system to improve speed and effectiveness of responses.
Reporting
Within 180 days of enactment, the Secretary must provide an unclassified report detailing the implementation plan to the relevant congressional committees, with a classified annex if necessary. This ensures transparency while permitting sensitive technical details to be restricted when appropriate.
Definitions
Key terms are defined to ground the program: artificial intelligence follows the NDAA 2019 definition; MedShield refers to BioShield as used in the NSCAI context; and the National Security Commission on Artificial Intelligence is the commission established under the NDAA.
Authorization of appropriations
The bill authorizes multi-year funding for MedShield: $300 million in FY2025, rising to $350 million in FY2026, $400 million in FY2027, $450 million in FY2028, and $500 million in FY2029, with the funds remaining available until expended.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- U.S. Department of Health and Human Services and its component agencies gain a formal, AI-enabled operating framework for preparedness and response.
- Public health and medical services entities at federal, state, and local levels benefit from coordinated, rapid access to countermeasures and data-driven decisions.
- Biotech and pharmaceutical companies, AI firms, and diagnostics developers benefit from a clear public-private pathway for innovation, data-sharing, and scaled manufacturing.
- Allies and international partners participate in interoperable systems, enabling faster collective action during pandemics.
- Patients and populations receive faster access to vaccines, therapeutics, and diagnostic tools through optimized deployment.
Who Bears the Cost
- Taxpayers fund multi-year appropriations to sustain AI-enabled pandemic readiness, with ongoing obligations for agencies to implement and maintain systems.
- Federal agencies outside HHS that participate in the program may incur coordination, data-sharing, and cybersecurity costs.
- Private sector partners may face compliance, data governance, and cybersecurity requirements to participate in public-private surveillance and manufacturing activities.
- State and local public health departments may incur costs to align with national plans and integrate data and response protocols.
- Ongoing oversight and potential regulatory burdens could shape how data is shared and how AI systems are audited.
Key Issues
The Core Tension
The central dilemma is balancing rapid AI-enabled response with the need for rigorous governance, privacy protections, and transparent accountability. Accelerating vaccine development and distribution via AI could outpace traditional regulatory review, while ensuring interagency collaboration and international coordination may require concessions on sovereignty and differing national standards.
The MedShield program rests on deploying advanced AI across a broad federal-public-private partnership. While this can increase readiness, it also raises questions about data governance, privacy, cybersecurity, and the risk of overreliance on automated systems for life-and-death decisions.
Implementing real-time surveillance and rapid manufacturing requires interoperable data standards, robust safeguarding against biases in AI models, and strong oversight to prevent misuse or unintended consequences across public and private actors. Without careful alignment of authorities and funding, there is a danger of duplicated efforts or gaps in accountability as multiple agencies and private entities coordinate across borders.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.